ELAN
Elanco Animal Health
NYSE: ELAN · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$21.80
-1.58% today
Updated 2026-04-29
Market cap
$10.89B
P/E ratio
—
P/S ratio
2.31x
EPS (TTM)
$-0.47
Dividend yield
—
52W range
$9 – $28
Volume
5.1M
Elanco Animal Health (ELAN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | $8.10B | $8.94B | $8.96B | $8.99B | $17.69B | $16.48B | $15.49B | $14.36B | $12.61B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — |
| Current assets | — | $1.95B | $2.12B | $2.50B | $2.37B | $3.42B | $3.27B | $3.28B | $3.41B | $3.21B |
| Total liabilities | — | $1.07B | $1.15B | $3.76B | $3.44B | $9.22B | $8.97B | $8.20B | $8.14B | $6.52B |
| Current liabilities | — | $618.90M | $632.60M | $970.70M | $818.50M | $2.08B | $1.65B | $1.70B | $1.24B | $1.31B |
| Long-term debt | — | — | — | $2.44B | $2.33B | $5.57B | $6.03B | $5.45B | $5.74B | $4.28B |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | — | $7.48B | $8.04B | $16.40M | $84.30M | $-477.00M | $-979.00M | $-1.06B | $-2.29B | $-1.95B |
| Accounts receivable | — | $630.70M | $601.90M | $709.40M | $889.90M | $1.08B | $1.03B | $1.00B | $1.01B | $886.00M |
| Inventory | — | $875.60M | $1.06B | $1.00B | $1.05B | $1.58B | $1.37B | $1.54B | $1.74B | $1.57B |
| Goodwill | — | $2.58B | $2.97B | $2.96B | $2.99B | $6.22B | $6.17B | $5.99B | $5.09B | $4.41B |